Younger patients showed a trend for better OS although the difference is not statistically significant; no differences in OS according to the presence/absence of Skin involvement or the history of previous RTX administration have been observed [ 109 ].
← all excerpts
Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside.
1
—
—